Cochrane Abstracts
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Corrector Therapies (with or Without Potentiators) for People With Cystic Fibrosis With Class II CFTR Gene Variants (most Commonly F508del)." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440217/all/Corrector_therapies__with_or_without_potentiators__for_people_with_cystic_fibrosis_with_class_II_CFTR_gene_variants__most_commonly_F508del_.
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del). Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440217/all/Corrector_therapies__with_or_without_potentiators__for_people_with_cystic_fibrosis_with_class_II_CFTR_gene_variants__most_commonly_F508del_. Accessed March 15, 2025.
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del). (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440217/all/Corrector_therapies__with_or_without_potentiators__for_people_with_cystic_fibrosis_with_class_II_CFTR_gene_variants__most_commonly_F508del_
Corrector Therapies (with or Without Potentiators) for People With Cystic Fibrosis With Class II CFTR Gene Variants (most Commonly F508del) [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440217/all/Corrector_therapies__with_or_without_potentiators__for_people_with_cystic_fibrosis_with_class_II_CFTR_gene_variants__most_commonly_F508del_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)
ID - 440217
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440217/all/Corrector_therapies__with_or_without_potentiators__for_people_with_cystic_fibrosis_with_class_II_CFTR_gene_variants__most_commonly_F508del_
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
